Fulviglen 250Mg/5Ml Inj belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.

Fulviglen 250Mg/5Ml Inj contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Fulviglen 250Mg/5Ml Inj will be administered by a healthcare professional; do not self-administer. In some cases, Fulviglen 250Mg/5Ml Inj may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fulviglen 250Mg/5Ml Inj do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulviglen 250Mg/5Ml Inj is not recommended for pregnant women as it may harm an unborn baby. Fulviglen 250Mg/5Ml Inj is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulviglen 250Mg/5Ml Inj. Avoid driving or operating machinery if you feel tired or weak after receiving Fulviglen 250Mg/5Ml Inj.

Fulviglen 250Mg/5Ml Inj contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulviglen 250Mg/5Ml Inj may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

• Injection site reactions such as inflammation or pain
• Weakness
• Nausea
• Tiredness
• Headache
• Joint and musculoskeletal pain

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulviglen 250Mg/5Ml Inj is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Fulviglen 250Mg/5Ml Inj and for two years after the last dose is advised. Fulviglen 250Mg/5Ml Inj is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulviglen 250Mg/5Ml Inj. Avoid driving or operating machinery if you feel tired or weak after receiving Fulviglen 250Mg/5Ml Inj.

Drug-Drug Interaction: If you are taking blood thinners, other anti-cancer medicines, tamoxifen or any medicine containing oestrogen (female sex hormone), inform your doctor.

Drug-Food Interaction: No interactions found.

Drug-Disease Interaction: If you have osteoporosis (loss of bone density), previous problems with blood clots, bleeding disorders or low numbers of platelets (which help blood clotting), and liver or kidney problems, inform your doctor before receiving Fulviglen 250Mg/5Ml Inj.

• TAMOXIFEN

• Avoid fried and processed foods.
• Include fibre-rich foods such as whole grains, fruits, and vegetables in your diet.
• Avoid refined carbohydrates that are high in sugars.
• Replace animal proteins (like eggs, fish, and meat) with vegetable protein sources (nuts, seeds, and beans).
• Avoid drinking excess alcohol or caffeinated drinks, as they can worsen the symptoms.
• Maintain a healthy weight and do moderate exercise regularly.
• Avoid smoking and alcohol intake.

Breast cancer: It is a type of cancer that develops in the breast when the cells grow abnormally. The tumor cells invade other healthy breast cells and can travel to lymph nodes, a primary pathway for the cancer cells to move to other parts of the body. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.